Renata PLC's latest marketcap:
As of 07/05/2025, Renata PLC's market capitalization has reached $452.87 M. According to our data, Renata PLC is the 14775th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 452.87 M |
| Revenue (ttm) | 335.96 M |
| Net Income (ttm) | 22.83 M |
| Shares Out | 114.7 M |
| EPS (ttm) | 0.2 |
| Forward PE | 22.32 |
| Ex-Dividend Date | 10/22/2024 |
| Earnings Date | 10/09/2025 |
Renata PLC's yearly market capitalization.
| Date | Market Cap(BDT) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 452.87 M | -23.4% | 14775 |
| 12/30/2024 | 72.84 B | -47.85% | 11742 |
| 12/27/2023 | 139.69 B | 0% | 7478 |
| 12/29/2022 | 139.69 B | -0.67% | 6883 |
| 12/30/2021 | 140.64 B | 30.38% | 6906 |
| 12/30/2020 | 107.87 B | 11.04% | 6939 |
| 12/30/2019 | 97.14 B | 5.65% | 6335 |
| 12/27/2018 | 91.94 B | 16.78% | 5819 |
| 12/28/2017 | 78.73 B | 19.1% | 7356 |
| 12/29/2016 | 66.1 B | 1.23% | 7285 |
Company Profile
About Renata PLC
Renata PLC is a leading manufacturer, marketer, and distributor of pharmaceuticals, animal health products, and vaccines in Bangladesh. The company operates across multiple segments, including human healthcare, animal health, and consumer products.
Product Portfolio
Human Pharmaceuticals:
- Antimicrobials, anti-hypertensive, and anti-diabetic medications
- Cardiovascular, CNS, and hormone therapies
- Anti-cancer, anti-asthma, and antiviral treatments
- Vitamins, minerals, and nutritional supplements
Animal Health Products:
- Antibiotics, antiparasitics, and antifungals
- Poultry and aqua products
- Live and killed vaccines
- Nutritional premixes and metabolic products
Other Offerings:
- Oncology-based products
- Agro-based solutions
- Consumer healthcare items
Company Background
Originally established as Pfizer Laboratories (Bangladesh) Limited in 1972, the company rebranded as Renata Limited in 1993. Headquartered in Dhaka, Renata PLC has grown into a key player in Bangladesh's pharmaceutical and healthcare industry.
Frequently Asked Questions
-
What is Renata PLC's (DSE-RENATA) current market cap?As of 07/05/2025, Renata PLC (including the parent company, if applicable) has an estimated market capitalization of $452.87 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Renata PLC (DSE-RENATA) rank globally by market cap?Renata PLC global market capitalization ranking is approximately 14775 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.